Education
About Us
Working with TipRanks
Follow Us
Island Pharmaceuticals Ltd (AU:ILA)
ASX:ILA
Total Valuation
Island Pharmaceuticals Ltd has a market cap or net worth of AU$88.88M. The enterprise value is AU$20.79M.
Market CapAU$88.88M
Enterprise ValueAU$20.79M
Share Statistics
Island Pharmaceuticals Ltd has 253,956,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding253,956,760
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Island Pharmaceuticals Ltd’s return on equity (ROE) is -0.55 and return on invested capital (ROIC) is -74.89%.
Return on Equity (ROE)-0.55
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-74.89%
Return on Capital Employed (ROCE)-0.75
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.02
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Island Pharmaceuticals Ltd is ―. Island Pharmaceuticals Ltd’s PEG ratio is 0.22.
PE Ratio―
PS Ratio204.10
PB Ratio3.39
Price to Fair Value3.39
Price to FCF-8.77
Price to Operating Cash Flow-20.34
PEG Ratio0.22
Income Statement
In the last 12 months, Island Pharmaceuticals Ltd had revenue of 118.91K and earned -3.92M in profits. Earnings per share was -0.02.
Revenue118.91K
Gross Profit-1.29M
Operating Income-5.36M
Pretax Income-3.92M
Net Income-3.92M
EBITDA0.00
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -2.77M and capital expenditures -5.00, giving a free cash flow of -2.77M billion.
Operating Cash Flow-2.77M
Free Cash Flow-2.77M
Free Cash Flow per Share-0.01
Dividends & Yields
Island Pharmaceuticals Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change178.57%
50-Day Moving Average0.32
200-Day Moving Average0.21
Relative Strength Index (RSI)53.51
Average Volume (3m)781.24K
Important Dates
Island Pharmaceuticals Ltd upcoming earnings date is Feb 19, 2026, TBA (Not Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend Date―
Financial Position
Island Pharmaceuticals Ltd as a current ratio of 22.27, with Debt / Equity ratio of 0.00%
Current Ratio22.27
Quick Ratio22.27
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio-196.28
Taxes
In the past 12 months, Island Pharmaceuticals Ltd has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Island Pharmaceuticals Ltd EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -6.15.
EV to Sales143.11
EV to EBITDA0.00
EV to Free Cash Flow-6.15
EV to Operating Cash Flow-6.15
Balance Sheet
Island Pharmaceuticals Ltd has AU$7.25M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$7.25M billion.
Cash & Marketable SecuritiesAU$7.25M
Total DebtAU$0.00
Net CashAU$7.25M
Net Cash Per ShareAU$0.03
Tangible Book Value Per ShareAU$0.04
Margins
Gross margin is -325.07%, with operating margin of -4507.49%, and net profit margin of -3296.73%.
Gross Margin-325.07%
Operating Margin-4507.49%
Pretax Margin-3296.73%
Net Profit Margin-3296.73%
EBITDA Margin0.00%
EBIT Margin-3326.06%
Analyst Forecast
The average price target for Island Pharmaceuticals Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast26.38%